Skip to Main Content

Author Details

J??rn Kamradt
Clinic of Urology and Pediatric Urology, University of Saarland
1996
53
17
PMIDPaper TitleJournal TitlePublished Year
37198025Adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible high-risk bladder cancer patients: Long-term follow-up of a randomized phase 3 trial.Urol Oncol2023
37198025Adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible high-risk bladder cancer patients: Long-term follow-up of a randomized phase 3 trial.Urol Oncol2023
35515270Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.Eur Urol Open Sci2022
35515270Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses.Eur Urol Open Sci2022
35740605Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer.Cancers (Basel)2022
35740605Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer.Cancers (Basel)2022
29209755[Evaluation of a prostate cancer E⿿health tutorial : Development and testing of the website prostata-information.ch].Urologe A2018
30044478Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).Swiss Med Wkly2018
30182362Correction to: Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).Swiss Med Wkly2018
29209755[Evaluation of a prostate cancer E⿿health tutorial : Development and testing of the website prostata-information.ch].Urologe A2018
30182362Correction to: Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).Swiss Med Wkly2018
30044478Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).Swiss Med Wkly2018
25115765High-resolution ultrasound allows percutaneous initiation and surveillance of prostate cancer in an orthotopic murine model.Urol Int2015
26074274Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.Prostate2015
26575991Quality of Preoperative Biopsy Is a Risk Factor for Positive Surgical Margins in Organ-Confined Prostate Cancer Treated with Nerve-Sparing Robot-Assisted Radical Prostatectomy.Urol Int2015
25115765High-resolution ultrasound allows percutaneous initiation and surveillance of prostate cancer in an orthotopic murine model.Urol Int2015
26575991Quality of Preoperative Biopsy Is a Risk Factor for Positive Surgical Margins in Organ-Confined Prostate Cancer Treated with Nerve-Sparing Robot-Assisted Radical Prostatectomy.Urol Int2015
26074274Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.Prostate2015
24246407A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer.Eur Urol2014
24246407A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer.Eur Urol2014
24428685Margin status of the vas deferens in radical prostatectomy specimens: relevant or waste of time?Histopathology2014
24053564Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05).BJU Int2014
24428685Margin status of the vas deferens in radical prostatectomy specimens: relevant or waste of time?Histopathology2014
24053564Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05).BJU Int2014
22520041[Initial experience of a series of robotic-assisted laparoscopic adrenalectomy].Actas Urol Esp2013
22520041[Initial experience of a series of robotic-assisted laparoscopic adrenalectomy].Actas Urol Esp2013
23145578Fast-track rehabilitation after robot-assisted laparoscopic cystectomy accelerates postoperative recovery.BJU Int2013
23145578Fast-track rehabilitation after robot-assisted laparoscopic cystectomy accelerates postoperative recovery.BJU Int2013
20452251Experimental orthotopic prostate tumor in nude mice: techniques for local cell inoculation and three-dimensional ultrasound monitoring.Urol Oncol2012
22526187[Radical cystectomy - pro robotic].Urologe A2012
22765865Robotic-assisted laparoscopic radical cystectomy: surgical and oncological outcomes.Int Braz J Urol2012
22996421[Mistletoe extract for treatment of urological tumors].Urologe A2012
23196778[Nephron-sparing surgery 2012].Aktuelle Urol2012
24826337Fatal multiorgan failure associated with disseminated herpes simplex virus-1 infection: a case report.Case Rep Crit Care2012
20452251Experimental orthotopic prostate tumor in nude mice: techniques for local cell inoculation and three-dimensional ultrasound monitoring.Urol Oncol2012
22113551[Third generation anti-androgen therapy of advanced prostate cancer].Urologe A2012
24826337Fatal multiorgan failure associated with disseminated herpes simplex virus-1 infection: a case report.Case Rep Crit Care2012
23196778[Nephron-sparing surgery 2012].Aktuelle Urol2012
22996421[Mistletoe extract for treatment of urological tumors].Urologe A2012
22765865Robotic-assisted laparoscopic radical cystectomy: surgical and oncological outcomes.Int Braz J Urol2012
22526187[Radical cystectomy - pro robotic].Urologe A2012
22113551[Third generation anti-androgen therapy of advanced prostate cancer].Urologe A2012
20669223Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.Int J Cancer2011
21345519[Robotic-assisted laparoscopic radical cystectomy: evaluation of functional and oncological results].Actas Urol Esp2011
20669223Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.Int J Cancer2011
21728008[From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].Urologe A2011
21863408[Current developments in the diagnostics and therapy of bladder carcinoma].Urologe A2011
21863408[Current developments in the diagnostics and therapy of bladder carcinoma].Urologe A2011
21728008[From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].Urologe A2011
21345519[Robotic-assisted laparoscopic radical cystectomy: evaluation of functional and oncological results].Actas Urol Esp2011
  • 1 - 50 of 106

Recommended Authors

Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 0
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 0
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1999
Number of shared co-authors 0
Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 0
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 0
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 0
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 1
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 0
Penny Flohr
The Institute of Cancer Research
Career Start Year 1993
Number of shared co-authors 0
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 0
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Career Start Year 1989
Number of shared co-authors 0
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 0
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 0
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 0
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 0
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 0
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 0
Dominique Trudel
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 0
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 0
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 2
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Career Start Year 1983
Number of shared co-authors 1
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 0
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 1
David E Neal
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 0
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 0
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 0
Yves Fradet
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 0
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 1
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Co-authored papers 13
Volker Jung
Clinic of Urology and Pediatric Urology, University of Saarland
Co-authored papers 12
Michael Stoeckle
Saarland University
Co-authored papers 6
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Rainer M Bohle
Co-authored papers 1
Martin K Schilling
University Hospital of Homburg/Saar (DE)
Co-authored papers 1
J??rg Rahnenf??hrer
TU Dortmund University
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Laura Tolosi
Max-Planck-Institute for Informatics
Co-authored papers 1
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Kerstin Wahrheit
Co-authored papers 1
Release 1.2